Stay updated on Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Lung cancer is added to related topics with a MedlinePlus Genetics link for educational resources.
    Difference
    0.2%
    Check dated 2025-10-27T20:46:22.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and removed MedlinePlus Genetics topic: Lung cancer; added a government funding/operating status notice referencing NIH and OPM.
    Difference
    3%
    Check dated 2025-10-06T07:52:26.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Core content updated with a new MedlinePlus Genetics topic on Lung cancer and a version upgrade to v3.1.0; older revision reference v3.0.2 was removed.
    Difference
    0.2%
    Check dated 2025-09-29T04:10:58.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Removed a MedlinePlus Genetics topic entry for Lung cancer from the page, reducing coverage of that topic without adding new content.
    Difference
    0.2%
    Check dated 2025-09-22T00:38:34.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Page updated to revision v3.0.2, replacing v3.0.1. The Back to Top link was removed, with no other substantive changes observed.
    Difference
    0.1%
    Check dated 2025-09-14T21:44:14.000Z thumbnail image
  8. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated to include information on Lung cancer under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.
    Difference
    0.3%
    Check dated 2025-09-07T18:10:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page.